Skip to main content
SRZN
NASDAQ Life Sciences

10% Owner Increases Stake in Surrozen with $641K Open Market Purchases

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$18.26
Mkt Cap
$154.114M
52W Low
$5.9
52W High
$24.94
52W Position info
209% above low
Off High info
27% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

SRZN has more than doubled off its 52-week low of $5.9.

Summary

A significant 10% owner, associated with The Column Group, made open market purchases of Surrozen stock totaling over $641,000, demonstrating strong conviction by buying at a premium to the current market price.


Key Events · Ownership and Investor Activity · SRZN

  • Significant Insider Buying

    The Column Group, a 10% owner, acquired 32,507 shares of Surrozen common stock through open market purchases.

  • Substantial Investment

    The total value of these open market purchases amounted to $641,597.

  • Premium Purchase Price

    Transactions were executed at prices between $19.60 and $20.00, exceeding the current market price of $18.26.

  • Increased Stake

    Following these transactions, the reporting owners collectively hold 1,016,658 shares.


Analysis · SRZN · Life Sciences

The Column Group, a significant 10% owner of Surrozen, has substantially increased its stake through multiple open market purchases totaling $641,597. These transactions occurred at prices ranging from $19.60 to $20.00, which is notably above the current stock price of $18.26. This aggressive buying at a premium suggests strong confidence in the company's future prospects from a major institutional investor with close ties to the board. Such a substantial investment from a key stakeholder can be interpreted as a bullish signal for the stock.

At the time of this filing, SRZN was trading at $18.26 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $154.1M. The 52-week trading range was $5.90 to $24.94. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SRZN - Latest Insights

SRZN
May 18, 2026, 6:49 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $28.15
Real-time Price: $19.40 info
Change: -$8.75 (-31%) info
Market Cap: $225.241M info
SRZN
May 06, 2026, 4:49 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $34.13
Real-time Price: $19.40 info
Change: -$14.73 (-43%) info
Market Cap: $225.241M info
SRZN
May 06, 2026, 4:38 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $34.13
Real-time Price: $19.40 info
Change: -$14.73 (-43%) info
Market Cap: $225.241M info
SRZN
Mar 30, 2026, 6:21 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $27.45
Real-time Price: $19.40 info
Change: -$8.05 (-29%) info
Market Cap: $225.241M info
SRZN
Mar 25, 2026, 8:02 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $26.14
Real-time Price: $19.40 info
Change: -$6.74 (-26%) info
Market Cap: $225.241M info